Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Esophageal Squamous Cell Carcinoma”

367 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 367 results

Testing effectiveness (Phase 2)UnknownNCT05522894
What this trial is testing

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Who this might be right for
Unresectable Esophageal Squamous Cell CarcinomaLocally Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)UnknownNCT01688700
What this trial is testing

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma Resectable
Zhejiang Cancer Hospital 60
Not applicableStudy completedNCT00004867
What this trial is testing

Positron Emission Tomography in Determining Stage of Esophageal Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 235
Testing effectiveness (Phase 2)UnknownNCT05541445
What this trial is testing

Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT06429839
What this trial is testing

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Who this might be right for
Esophageal CancerNimotuzumabChemoradiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Testing effectiveness (Phase 2)Looking for participantsNCT06354218
What this trial is testing

Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Who this might be right for
Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06747585
What this trial is testing

Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Who this might be right for
Squamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell Carcinoma+1 more
Alentis Therapeutics AG 170
Testing effectiveness (Phase 2)Looking for participantsNCT07733830
What this trial is testing

Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT03913182
What this trial is testing

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaApatinibRecurrence+1 more
Shanghai Chest Hospital 39
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00915850
What this trial is testing

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Cancer
Wakayama Medical University 32
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00002984
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05182944
What this trial is testing

Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 130
Large-scale testing (Phase 3)Active Not RecruitingNCT05043688
What this trial is testing

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li 426
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711470
What this trial is testing

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Looking for participantsNCT05507411
What this trial is testing

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01831531
What this trial is testing

Study of S-1 in Combination With Radiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 105
Testing effectiveness (Phase 2)Study completedNCT00069953
What this trial is testing

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 43
Next Page